[1]  Rafael B E，Claudio C W，Paulo A S M，et al. Major glycosaminoglycan species in the developing retina:synthesis tissue distribution and effects upon cell death[J]. Exp Eye Res，2003，77(2)：157-165.

[2]  Yu Guang-li(于广利). Preparation of Series Sulfated Oligosaccharides and Their Structural and Sequential Analysis (系列硫酸寡糖的制备及其结构与序列分析)[D]. QingDao(青岛）：Ocean University of China(中国海洋大学)，2007.

[3]  Jiang Zhen-Ju(蒋珍菊)，Wang Zhou-Yu(王周玉)，Hu Xing-Qi(胡星琪). Research on the blood anticoagulation performance of chitosan heparinoids（壳聚糖类肝素衍生物抗凝血性能研究)[J]. Chemistry & Bioengineering(化学与生物工程)，2008，25 (12)： 57-59.

[4]  Wang Dan（王丹). The experts of several countries discuss “heparin sodium events”(多国专家会诊“肝素钠事件”)[N]. Medicine Economic News(医药经济报)，2008-04-25(001).

[5]  Wang Hao(王皓)，Yu Guang-li(于广利)，Zhao Xia(赵峡)，et al. Two steps cellulose acetate membrane electrophoresis analysis of oversulfated chondroitin sulfate in contaminated heparin(污染肝素中多硫酸软骨素的分布醋酸纤维素薄膜电泳分析)[J]. Chinese J Anal Chem(分析化学)，2009，37（8）：1 147-1 151.

[6]  Xu Hong(徐红)，Liu Shao-pu（刘绍璞），Luo Hong-qun（罗红群），et al. Determination of heparin with basic bisphenylnaphthylmethane dyes by fading spectrophotometry(碱性二苯基萘基甲烷染料褪色分光光度法测定肝素)[J]. Chem J Chinese Universities(高等学校化学学报)，2002，23(2)：216-218.

[7]  Zhang Z Q，Weiwer M，Li Boyangzi，et al. Impact of a heparin impurity, associated with adverse clinical events, on lowmolecular-weight heparin preparation[J]. J Med Chem, 2008，51(18)：5 498-5 501.

[8]  McEwen I，Rundlof T，EkM，et al. Effect of Ca²⁺ on the ¹H NMR chemical shift of the methyl signal of oversulphatedchondroitinsulphate, a contaminant in heparin[J]. J Pharm Biomed Anal，2009，49(3)：816-819.

[9]  McEwen I，Mulloy B，Hellwig E，et al. Determination of oversulphated chondroitin sulphate and dermatan sulphate in unfractionatedheparin by ¹H-NMR-Collaborative study for quantification and analytical determination of LoD[J]. Pharm  Biol， 2008，2008(1)：31-39.

[10]  Zhang Z Q，McCallum S A，Jin X，et al. Solution Structures of chemoenzymatically synthesized heparin and its precursors
[J]. J Am Chem Soc，2008，130：12 998-13 007.

[11]  Juan C C，Javier S. MestReNova[CP]. MestreLab ResearchSL CO，2004.

[12]  Sim J S，Jun G，Toida T，et al. Quantitative analysis of chondroitin sulfate in raw materials, ophthalmic solutions, soft capsules and liquid preparations[J]. J Chromatogr B: Analyt Technol Biomed Life Sci，2005，818(2)：133-139.

[13]  Li Xin(李鑫)，Yao Kai(姚开)，Jia Dong-ying(贾冬英)，et al. Progress in extraction purification and separation of chondroitin sulfate(硫酸软骨素的提取和纯化分离技术)[J]. Natural Product Research and Development(天然产物研究与开发)，2004，16(6)： 597-600.

[14]  Yu Guang-li（于广利），Guan Hua-shi（管华诗）. Isolation and preparation of dermatan sulfate oligosaccharides (硫酸皮肤素寡糖的分离与制备)[J]. Journal of Ocean University of Qingdao(中国海洋大学学报)，2001，31(6)：849-854.

[15]  Zhang You-jie(张友杰)，Liu Xiao-peng（刘小鹏）. Studies of NMR acquisition parameters for quantitative analysis of drugs(药物核磁共振定量分析参数的研究)[J]. Chinese J Magn Reson(波谱学杂志)，2007，24(3)：289-295.

[16]  Sha Yi(沙沂)，Li Wen(李文)，Shen Hui-en(申会恩). Determination of clarithromycin content by NMR(克拉霉素胶囊的NMR定量方法研究)[J]. Chinese J Magn Reson(波谱学杂志)，2009，26(3)：308-315.

[17]  Jiang Wen（蒋文），Su Mei(苏敏)，Chen Shuang-quan(陈双全)，et al. Determination of indiplon by proton Nuclear Magnetic Resonance spectrometry with internal standard method(核磁共振氢谱内标法测定茚地普隆的含量)[J]. Chinese J Anal Chem(分析化学)，2008，36（3）：385-388.